A股異動 | 光威復材漲5% 全資子公司簽訂11.06億元訂貨合同
格隆匯12月10日丨光威復材(300699.SZ)盤中漲5.03%,報86.23元,總市值447億元。光威復材12月9日發佈公吿,全資子公司威海拓展與客户A簽訂了三個訂貨合同,合同標的為某型號碳纖維及織物,合同總額11.06億元,佔公司最近一個會計年度營業收入的52.28%,合同履行將對公司利潤產生重大積極影響。另外,公司某型號碳纖維原絲生產線等同性驗證通過。此次等同性驗證通過後,將有效緩解公司該型號碳纖維原絲產能瓶頸問題,使該型號碳纖維產能增至500噸左右,為我國部分航空裝備應用發展提供重要材料保障。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.